I. Bereznyakov
I. Bereznyakov has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
O. Zalubovska
Kharkiv National Medical University
3 shared publications- M. Bereznyakova
Kharkiv National Medical University
2 shared publications І.г. Березняков
ГО «Українська асоціація за доцільне використання антибіотиків», Харків, Україна
2 shared publicationsМ.є. Березнякова
Харківський національний медичний університет, Харків, Україна
2 shared publicationsМ.і. Литвиненко
Харківський національний медичний університет, Харків, Україна
2 shared publicationsО.і. Залюбовська
Харківський національний медичний університет, Харків, Україна
2 shared publications
Latest Publications
- Open Access
- 30 June 2025
- Published by Kharkiv National Medical University in Experimental and Clinical Medicine
- Vol. 94 (2) , 116
Clinical interpretation of elevated serum creatinine levels (lecture)
Measurement of serum creatinine is an important test for assessing kidney function. Among several methods of laboratory measurement of creatinine, isotope dilution mass spectrometry is considered the most accurate. The colorimetric Jaffe method is commonly used in clinical practice, but is subject to interference by a range of substances. The amount of creatinine the body produces each day depends on the person's muscle mass. Plasma creatinine levels vary substantially (with coefficient of variability from 8% to 27%), mostly due to the effects of diet and of intra- and inter-patient variability in the production, tubular secretion, and renal and extra-renal excretion and degradation of creatinine. There are pre-renal, renal and post-renal causes of elevated creatinine. Urea/serum creatinine ratio can help distinguish pre-renal from renal causes. A ratio >100 suggests pre-renal causes, whereas a ratio <40 suggests renal causes. The typical rise in serum creatinine in acute kidney injury is 88 to 177 µmol/L/day. Suspicion of rapidly progressive glomerulonephritis or rhabdomyolysis should arise in cases of more prominent rise in serum creatinine. Rises in creatinine are delayed for approximately [12–24] hours following kidney injury. When evaluating the causes of increased serum creatinine, significant importance is attached to the analysis of the drugs that the patient was taking. Antibacterial and antiviral agents, nonsteroidal anti-inflammatory agents, and proton pump inhibitors have the greatest nephrotoxic potential. A decrease in glomerular filtration rate under the influence of inhibitors of the renin-angiotensin-aldosterone system is more often a sign of the effective action of the drugs than of acute kidney injury. Diuretics do not cause acute kidney injury if not used excessively. Rise in serum creatinine is associated with an increased risk of end-stage renal disease and death, although some causes of the increased serum creatinine are reversible. Keywords: laboratory measurement, kidney injury, nephrotoxicity of drugs.
- 30 June 2025
- Published by Kharkiv National Medical University in Experimental and Clinical Medicine
- Vol. 94 (2) , 116
Open AccessClinical interpretation of elevated serum creatinine levels (lecture)
Measurement of serum creatinine is an important test for assessing kidney function. Among several methods of laboratory measurement of creatinine, isotope dilution mass spectrometry is considered the most accurate. The colorimetric Jaffe method is commonly used in clinical practice, but is subject to interference by a range of substances. The amount of creatinine the body produces each day depends on the person's muscle mass. Plasma creatinine levels vary substantially (with coefficient of variability from 8% to 27%), mostly due to the effects of diet and of intra- and inter-patient variability in the production, tubular secretion, and renal and extra-renal excretion and degradation of creatinine. There are pre-renal, renal and post-renal causes of elevated creatinine. Urea/serum creatinine ratio can help distinguish pre-renal from renal causes. A ratio >100 suggests pre-renal causes, whereas a ratio <40 suggests renal causes. The typical rise in serum creatinine in acute kidney injury is 88 to 177 µmol/L/day. Suspicion of rapidly progressive glomerulonephritis or rhabdomyolysis should arise in cases of more prominent rise in serum creatinine. Rises in creatinine are delayed for approximately [12–24] hours following kidney injury. When evaluating the causes of increased serum creatinine, significant importance is attached to the analysis of the drugs that the patient was taking. Antibacterial and antiviral agents, nonsteroidal anti-inflammatory agents, and proton pump inhibitors have the greatest nephrotoxic potential. A decrease in glomerular filtration rate under the influence of inhibitors of the renin-angiotensin-aldosterone system is more often a sign of the effective action of the drugs than of acute kidney injury. Diuretics do not cause acute kidney injury if not used excessively. Rise in serum creatinine is associated with an increased risk of end-stage renal disease and death, although some causes of the increased serum creatinine are reversible. Keywords: laboratory measurement, kidney injury, nephrotoxicity of drugs.
- Open Access
- 27 December 2023
- Published by Kharkiv National Medical University in Medicine Today and Tomorrow
- Vol. 92 (4)
Clinical and laboratory diagnostics of drug-induced liver injury by antibiotics
In press Liver damage in a patient can precede the prescribing of antibiotics for the treatment of an infectious disease, may occur during their use or after their discontinuation. Liver damage before the start of treatment limits the choice and affects the dosage of antimicrobial agents. The occurrence of liver damage during antimicrobial treatment or after discontinuation of antibiotics can be both a consequence of this intake and independent of treatment with antibacterial drugs. Diagnosis of such lesions requires the use of many clinical, laboratory and instrumental investigations. The key element of diagnosis is the determination of the biochemical variant of liver damage, which makes it possible to plan the sequence of differential diagnosis. In case of suspicion of drug-induced damage to the liver, it is necessary to stop taking immediately the drugs that allegedly caused it. The next step is finding out the connection between the use of the antibiotic and the occurrence of the disease, taking into account the data of the literature regarding this possibility. Then it is necessary to estimate compatibility in time between the start of the use of drugs and the appearance of signs of liver damage, to assess the severity of the injury and, if possible, to prescribe appropriate medicines. There are several methods to assess causality between drugs and liver injury with RUCAM on the head. LiverTox is a well-known database on medicines, which are capable to cause liver damage. Antimicrobial agents belong to the most frequent causes of drug-induced liver injury. Most of such injuries are idiosyncratic. There was used a clinical example of possible drug-induced liver damage to illustrate decisions and difficulties in proving the etiological role of an antibiotic in a case, when liver damage arose during management of a patient with community-acquired pneumonia. This article is a clinical lecture. Keywords: toxic action, biochemical variant, antimicrobials. In press У хворого ураження печінки може передувати призначенню антибіотиків для лікування інфекційного захворювання, виникати під час їх використання або вже після їх припинення. Наявне до початку лікування ушкодження печінки обмежує вибір і впливає на дозування антимікробних засобів. Виникнення ураження печінки під час прийому антибіотиків чи після його завершення може бути як наслідком цього прийому, так і не залежати від лікування антибактеріальними препаратами. Діагностика подібних уражень потребує застосування багатьох клінічних, лабораторних і інструментальних досліджень. Ключовим елементом діагностики є визначення біохімічного варіанту ушкодження печінки, що дає змогу спланувати послідовність диференційної діагностики. У разі підозри на лікарське ураження печінки слід негайно припинити прийом препаратів, які передбачувано викликали його, з’ясувати зв’язок між застосуванням антибіотика і виникненням захворювання з урахуванням даних літератури стосовно такої можливості, сумісності у часі між початком використання ліків і появою ознак ушкодження печінки, оцінити тяжкість ураження, за можливості – призначити доцільні ліки. Ця стаття є клінічною лекцією. Ключові слова: токсична дія, біохімічний варіант, антимікробні засоби.
- 27 December 2023
- Published by Kharkiv National Medical University in Medicine Today and Tomorrow
- Vol. 92 (4)
Open AccessClinical and laboratory diagnostics of drug-induced liver injury by antibiotics
In press Liver damage in a patient can precede the prescribing of antibiotics for the treatment of an infectious disease, may occur during their use or after their discontinuation. Liver damage before the start of treatment limits the choice and affects the dosage of antimicrobial agents. The occurrence of liver damage during antimicrobial treatment or after discontinuation of antibiotics can be both a consequence of this intake and independent of treatment with antibacterial drugs. Diagnosis of such lesions requires the use of many clinical, laboratory and instrumental investigations. The key element of diagnosis is the determination of the biochemical variant of liver damage, which makes it possible to plan the sequence of differential diagnosis. In case of suspicion of drug-induced damage to the liver, it is necessary to stop taking immediately the drugs that allegedly caused it. The next step is finding out the connection between the use of the antibiotic and the occurrence of the disease, taking into account the data of the literature regarding this possibility. Then it is necessary to estimate compatibility in time between the start of the use of drugs and the appearance of signs of liver damage, to assess the severity of the injury and, if possible, to prescribe appropriate medicines. There are several methods to assess causality between drugs and liver injury with RUCAM on the head. LiverTox is a well-known database on medicines, which are capable to cause liver damage. Antimicrobial agents belong to the most frequent causes of drug-induced liver injury. Most of such injuries are idiosyncratic. There was used a clinical example of possible drug-induced liver damage to illustrate decisions and difficulties in proving the etiological role of an antibiotic in a case, when liver damage arose during management of a patient with community-acquired pneumonia. This article is a clinical lecture. Keywords: toxic action, biochemical variant, antimicrobials. In press У хворого ураження печінки може передувати призначенню антибіотиків для лікування інфекційного захворювання, виникати під час їх використання або вже після їх припинення. Наявне до початку лікування ушкодження печінки обмежує вибір і впливає на дозування антимікробних засобів. Виникнення ураження печінки під час прийому антибіотиків чи після його завершення може бути як наслідком цього прийому, так і не залежати від лікування антибактеріальними препаратами. Діагностика подібних уражень потребує застосування багатьох клінічних, лабораторних і інструментальних досліджень. Ключовим елементом діагностики є визначення біохімічного варіанту ушкодження печінки, що дає змогу спланувати послідовність диференційної діагностики. У разі підозри на лікарське ураження печінки слід негайно припинити прийом препаратів, які передбачувано викликали його, з’ясувати зв’язок між застосуванням антибіотика і виникненням захворювання з урахуванням даних літератури стосовно такої можливості, сумісності у часі між початком використання ліків і появою ознак ушкодження печінки, оцінити тяжкість ураження, за можливості – призначити доцільні ліки. Ця стаття є клінічною лекцією. Ключові слова: токсична дія, біохімічний варіант, антимікробні засоби.
- Open Access
- 31 March 2023
- Published by Kharkiv National Medical University in Medicine Today and Tomorrow
- Vol. 92 (1)
Diagnosis and clinical significance of magnesium deficiency in the body
There are three groups of patients with abnormalities of magnesium homoeostasis. The first one include patients with magnesium deficiency (low total body magnesium content) and a resultant hypomagnesaemia (low serum magnesium concentration). Patients with hypomagnesaemia (serum magnesium concentration <0.75 mmol/L) in the absence of magnesium deficiency (i.e., a normal total body magnesium content) consist the second group. The third group include patients with magnesium deficiency (low total body magnesium content) but no evidence of hypomagnesaemia (i.e., a normal serum magnesium concentration). Magnesium deficiency can be caused by decreased magnesium intake from the diet, decreased magnesium absorption, or increased renal magnesium excretion (renal magnesium wasting). The narrative review examines the causes, clinical and laboratory signs of magnesium deficiency in the body, and the effect of magnesium supplementation on health indices. Groups of people who are more likely to suffer from magnesium deficiency are outlined. Emphasis is placed on the use of questionnaires to identify individuals with possible magnesium deficiency. The changes on the electrocardiograms that are characteristic of the initial magnesium deficiency and that occur in case of its increase are given. The effect of additional intake of magnesium salts on blood pressure changes in individuals with and without baseline hypertension is discussed in detail. Factors that make it difficult to assess the relationship between magnesium intake and abnormalities in lipid and carbohydrate metabolism are listed. An association between increased dietary magnesium intake and reduced risk of certain cardiovascular diseases, diabetes mellitus, and overall mortality has been demonstrated. Keywords: hypomagnesaemia, blood pressure, diabetes mellitus.
- 31 March 2023
- Published by Kharkiv National Medical University in Medicine Today and Tomorrow
- Vol. 92 (1)
Open AccessDiagnosis and clinical significance of magnesium deficiency in the body
There are three groups of patients with abnormalities of magnesium homoeostasis. The first one include patients with magnesium deficiency (low total body magnesium content) and a resultant hypomagnesaemia (low serum magnesium concentration). Patients with hypomagnesaemia (serum magnesium concentration <0.75 mmol/L) in the absence of magnesium deficiency (i.e., a normal total body magnesium content) consist the second group. The third group include patients with magnesium deficiency (low total body magnesium content) but no evidence of hypomagnesaemia (i.e., a normal serum magnesium concentration). Magnesium deficiency can be caused by decreased magnesium intake from the diet, decreased magnesium absorption, or increased renal magnesium excretion (renal magnesium wasting). The narrative review examines the causes, clinical and laboratory signs of magnesium deficiency in the body, and the effect of magnesium supplementation on health indices. Groups of people who are more likely to suffer from magnesium deficiency are outlined. Emphasis is placed on the use of questionnaires to identify individuals with possible magnesium deficiency. The changes on the electrocardiograms that are characteristic of the initial magnesium deficiency and that occur in case of its increase are given. The effect of additional intake of magnesium salts on blood pressure changes in individuals with and without baseline hypertension is discussed in detail. Factors that make it difficult to assess the relationship between magnesium intake and abnormalities in lipid and carbohydrate metabolism are listed. An association between increased dietary magnesium intake and reduced risk of certain cardiovascular diseases, diabetes mellitus, and overall mortality has been demonstrated. Keywords: hypomagnesaemia, blood pressure, diabetes mellitus.
- 1 January 2019
- Published by Scientific Society Anatomists, Histologists, and Embryologists, Ukraine in World of Medicine and Biology
- Vol. 15 (69) , 014-018
COMPARISON OF THERAPISTS’ AND FAMILY DOCTORS’ CONCEPTIONS CONCERNING DIAGNOSTICS AND TREATMENT OF ACUTE BRONCHITIS
Physicians’ mistakes in diagnostics and treatment of acute bronchitis (AB) lead to unnecessary drug costs and can negatively influence on spread of an
- 1 January 2019
- Published by Scientific Society Anatomists, Histologists, and Embryologists, Ukraine in World of Medicine and Biology
- Vol. 15 (69) , 014-018
COMPARISON OF THERAPISTS’ AND FAMILY DOCTORS’ CONCEPTIONS CONCERNING DIAGNOSTICS AND TREATMENT OF ACUTE BRONCHITIS
Physicians’ mistakes in diagnostics and treatment of acute bronchitis (AB) lead to unnecessary drug costs and can negatively influence on spread of an
- 1 June 2000
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 18, S27-S28
ANTIHYPERTENSIVE TREATMENT IN UKRAINE
- 1 June 2000
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 18, S27-S28
ANTIHYPERTENSIVE TREATMENT IN UKRAINE